Caribou Biosciences, Inc. CRBU
0.46 USD +0.02 (+4.43%)
At closeNov 3, 2026, 5:46 PM EST
0.42 -0.04 -8.12%
After hours · Nov 3, 5:46 PM ET
0.415 Day range 0.4646
0.41 52-week range 2.49
- YTD
- -71.11%
- 1 year
- -81.09%
Analyst view
Price target (mean) 12.50 +2620.9% upside
Now 0.4594
- Target (low)
- 3.00
- Target (mean)
- 12.50
- Target (high)
- 26.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy2
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.41804 | -0.47217 – -0.39 | -0.4091 | -2.2% | 1.84M | -48.2% | 4 |
| Next quarter | -0.44 | -0.44 – -0.44 | -0.4651 | +5.4% | 2.75M | +13.2% | 1 |
| Current year | -1.70 | -1.75 – -1.66 | -1.40 | -21.3% | 9.13M | -73.5% | 3 |
| Next year | -2.07 | -2.91 – -1.64 | -1.70 | -21.9% | 9.01M | -1.3% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | Citigroup | Maintained | Buy | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 7, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 4, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 16, 2024 | Truist Securities | Maintained | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 19, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 12, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Nov 8, 2023 | Cantor Fitzgerald | Initiated | — | Neutral |
| Jul 26, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 14, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Jul 11, 2023 | Truist Securities | Initiated | — | Buy |
| May 10, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 14, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 10, 2023 | RBC Capital | Reiterated | — | Outperform |
| Mar 10, 2023 | Oppenheimer | Maintained | — | Outperform |
| Aug 29, 2022 | Citigroup | Maintained | — | Buy |
| Aug 18, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 10, 2022 | RBC Capital | Maintained | — | Outperform |
| May 13, 2022 | Citigroup | Maintained | — | Buy |
| May 12, 2022 | SVB Leerink | Maintained | — | Outperform |
| May 10, 2022 | SVB Leerink | Maintained | — | Outperform |
| Mar 22, 2022 | SVB Leerink | Maintained | — | Outperform |
| Feb 18, 2022 | RBC Capital | Initiated | — | Outperform |
| Feb 14, 2022 | Brookline Capital | Initiated | — | Buy |
| Dec 1, 2021 | Oppenheimer | Initiated | — | Outperform |
| Nov 30, 2021 | HC Wainwright & Co. | Initiated | — | Buy |